Question 2: Does the timing of central line placement in relationship to the initiation of acute lymphoblastic leukaemia therapy change the risk of thrombosis or infection?: Table 1

Jamie N Frediani, Bob Phillips
  • Archives of Disease in Childhood, November 2014, BMJ
  • DOI: 10.1136/archdischild-2014-307156

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Bob Phillips